Surgical versus transcatheter aortic valve replacement in low-risk Medicare beneficiaries.

ABSTRACT:

Objective

Recent approval of transcatheter aortic valve replacement (TAVR) in patients at low surgical risk has resulted in a rapid real-world expansion of TAVR in patients not otherwise examined in recent low-risk trials. We sought to evaluate the outcomes of surgical aortic valve replacement (SAVR) versus TAVR in low-risk Medicare beneficiaries.

Methods

Using the US Centers for Medicare and Medicaid Services claims database, we evaluated all beneficiaries undergoing isolated SAVR (n = 33,210) or TAVR (n = 77,885) (2018-2020). International Classification of Diseases 10th revision codes were used to define variables and frailty was defined by the validated Kim index. Doubly robust risk adjustment was performed with inverse probability weighting and multilevel regression mod

SUBMITTER: Mehaffey JH 

PROVIDER: S-EPMC11513403 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature